These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35706816)

  • 21. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
    Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
    Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
    Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraneoplastic Cerebellar Degeneration Leading to an Early Diagnosis of Peritoneal Serous Papillary Carcinoma.
    Yasuda T; Shimizu J; Miyagawa T; Tsutsumi Y; Iwatsubo T; Tsuji S
    Intern Med; 2024 Mar; ():. PubMed ID: 38432969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rehabilitation for a patient with anti-Yo antibody-positive paraneoplastic cerebellar degeneration caused by breast cancer: A case report and literature review.
    Kato N; Hashida G; Konaka K
    Medicine (Baltimore); 2017 Nov; 96(44):e8468. PubMed ID: 29095299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature.
    Gungor S; Kilic B; Arslan M; Ozgen U
    Childs Nerv Syst; 2017 Mar; 33(3):509-512. PubMed ID: 27796550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
    Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
    J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade B-cell lymphoma with gastroduodenal involvement showing paraneoplastic cerebellar degeneration: a case report.
    Wang C; Yang Y; He Z; Wei X; Zhang S; Song J
    Transl Cancer Res; 2022 Dec; 11(12):4441-4447. PubMed ID: 36644173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Zic4 Paraneoplastic Cerebellar Degeneration With Mesial Temporal Lobe Hyperintensity in a Patient With Papillary Thyroid Carcinoma: A Case Report and Review of the Literature.
    Abuzahra S; Abuhassan A; Maree M; Makkawi M
    Cureus; 2023 Mar; 15(3):e36164. PubMed ID: 37065299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
    Phuphanich S; Brock C
    J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
    Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
    Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma.
    Ayas ZÖ; Uncu G
    Curr Oncol; 2021 Jan; 28(1):560-564. PubMed ID: 33477892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
    Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
    J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years.
    Christensen PB; Gregersen H; Almasi C
    Cerebellum Ataxias; 2021 Jun; 8(1):14. PubMed ID: 34090521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration Manifesting as Acute Cerebellitis with Posterior Cranial Fossa Hypertension.
    Enríquez-Marulanda A; Beltrán-Osorio LD; Escobar LA; Granados AM; Velásquez-Lasprilla F; Orozco JL
    World Neurosurg; 2018 Apr; 112():117-122. PubMed ID: 29378343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Yo and anti-glutamic acid decarboxylase antibodies presenting in carcinoma of the uterus with paraneoplastic cerebellar degeneration: a case report.
    Panegyres PK; Graves A
    J Med Case Rep; 2012 Jun; 6():155. PubMed ID: 22691265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration.
    Thöne J; Hohaus A; Lamprecht S; Bickel A; Erbguth F
    J Neurol Sci; 2008 Sep; 272(1-2):171-3. PubMed ID: 18632117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to abdominal hysterectomy with bilateral salpingo-oophorectomy in postmenopausal woman with anti-yo antibody mediated paraneoplastic cerebellar degeneration.
    Bhargava A; Bhushan B; Kasundra GM; Shubhakaran K; Pujar GS; Banakar B
    Ann Indian Acad Neurol; 2014 Jul; 17(3):355-7. PubMed ID: 25221413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma exchange for treating anti-Yo-associated paraneoplastic cerebellar degeneration: Case report and literature review.
    Hu FQ; Shang FR; Liu JJ; Yuan H
    Medicine (Baltimore); 2020 Aug; 99(33):e21760. PubMed ID: 32872070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.